Stefan K. Barta, MD¹, Ariela Noy, MD², Marcelo C Pasquini, MD, MS³, Naya He, MPH^4*, Tiffany Hunt, MS^5*, Carlos Litovich, MPH^6*, Uroosa Ibrahim, MD, MBBS^7*, Robert A. Baiocchi, MD, PhD⁸ and Richard F. Ambinder, MD, PhD⁹

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
⁴CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵CIBMTR, Medical College of Wisconsin, Milwaukee, WI
⁶CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁷Department of Hematology and Oncology, Bone Marrow Transplantation and Cellular Therapy Program, Mount Sinai Hospital, New York, NY
⁸Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
⁹Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD

Mariana Bastos-Oreiro, MD, PhD^1*, Antonio Gutierrez, MD, PhD^2*, Gloria Iacoboni, MD^3*, Lucía López Corral, MD PhD^4*, Juan Luis Reguera, MD^5*, Nuria Martínez-Cibrian, MD^6*, María José Terol, MD PhD^7*, Ana Carolina Carolina Caballero Gonzalez, MD^8*, Jaime Sanz, MD^9*, Luisa Maria Guerra, MD^10*, Pau Abrisqueta, MD, PhD^11*, Gillen Oarbeascoa, MD^12*, Javier Delgado^13*, Rafael Hernani, MD^14*, Alberto Mussetti^15*, Ana Jimenez-Ubieto, MD, PhD^16*, Juan-Manuel Sancho, MD, PhD^17*, Anna Sureda¹⁸, Antonio Perez, MD, PhD^19*, Pere Barba, MD, PhD^20*, Mi Kwon, MD, PhD^21* and Alejandro Martín García-Sancho, MD, PhD^22*

¹Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
²Hematology Department, Hospital Universitario Son Dureta, Palma, Spain
³Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, WA, Spain
⁴Department of Hematology, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
⁵Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain
⁶Hematology, Hospital Clinic Barcelona, Barcelona, Spain
⁷Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, Spain
⁸Hematology Department, Hospital de la Santa Creu i Sant Pau, BARCELONA, Spain
⁹Avinguda Fernando Abril Martorell, Hospital Universitario La Fe, Valencia, Valencia, Spain
¹⁰Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain
¹¹Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, Spain
¹²Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Madrid, Spain
¹³Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío, Sevilla, Spain
¹⁴Hematology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
¹⁵Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
¹⁶GELTAMO, Hospital Doce de Octubre, Madrid, Spain
¹⁷Clinical Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁸Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain
¹⁹Hemato-Oncology Pediatric Service, Hospital Universitario La Paz, Madrid, Spain
²⁰Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
²¹Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
²²Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain

Matthew A. Lunning, DO, FACP¹, Hai-Lin Wang, MPH^2*, Zhen-Huan Hu, MPH^2*, Frederick L. Locke, MD³, Tanya Siddiqi, MD⁴, Caron A. Jacobson, MD⁵, Sairah Ahmed, MD⁶, David B. Miklos, MD, PhD⁷, Yi Lin, MD, PhD⁸, Brian T. Hill, MD, PhD⁹, Armin Ghobadi, MD¹⁰, Sattva S. Neelapu, MD¹¹, Jason Westin, MD¹², Harry Miao, MD, PhD^2*, Shilpa Shahani, MD^2*, Anik R. Patel, PhD^2*, Clare Spooner, MBBS, BSc^2*, Christine Fu, PhD^2*, Hairong Xu, MD, PhD^2* and Marcelo C Pasquini, MD, MS¹³

¹University of Nebraska, Omaha, NE
²Kite, a Gilead Company, Santa Monica, CA
³Moffitt Cancer Center, Tampa, FL
⁴City of Hope National Medical Center, Duarte, CA
⁵Dana-Farber Cancer Institute, Boston, MA
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁸Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁹Cleveland Clinic Foundation, Cleveland, OH
¹⁰Washington University School of Medicine, Saint Louis, MO
¹¹Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
¹²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

Christopher J. Ferreri, MD¹, Michelle A.T. Hildebrandt, PhD¹, Hamza Hashmi, MD², Leyla O. Shune, MD³, Joseph P. McGuirk, DO⁴, Douglas W. Sborov, MD⁵, Charlotte B Wagner, PharmD^6*, M. Hakan Kocoglu, MD⁷, Shebli Atrash, MD⁸, Peter M. Voorhees, MD⁹, Jack Khouri, MD¹⁰, Danai Dima, MD¹⁰, Aimaz Afrough, MD¹¹, Aishwarya Sannareddy, MBBS^12*, Gary Simmons, DO¹³, James Davis, PharmD^2*, Nilesh Kalariya^1*, Lauren C. Peres, PhD, MPH^14*, Melissa Alsina, MD**¹⁵, Frederick L. Locke, MD¹⁶, Surbhi Sidana, MD¹⁷, Doris K. Hansen, MD¹⁸, Krina Patel, MD, MSc¹⁹ and Omar Alexis Castaneda Puglianini, MD²⁰

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴The University of Kansas Medical Center, Kansas City, KS
⁵Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT
⁶University of Utah Huntsman Cancer Institute, Salt Lake City, UT
⁷University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁸Levine Cancer Institute, Charlotte, NC
⁹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest Baptist, Charlotte, NC
¹⁰Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
¹¹Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
¹²Division of Hematologic Malignancies, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX
¹³Virginia Commonwealth University Massey Cancer Center, Richmond, VA
¹⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁵Moffitt Cancer Center, Tampa, FL
¹⁶Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁷Stanford University School of Medicine, Stanford, CA
¹⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
¹⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁰Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Jean Lemoine^1*, Emmanuel Bachy, MD, PhD^2*, Guillaume Cartron, MD, PhD^3*, David Beauvais, MD^4*, Thomas Gastinne, MD^5*, Marie Thérèse Rubio, MD, PhD^6*, Xavier Leleu, MD, PhD⁷, Mohamad Mohty, MD PhD⁸, René-Olivier Casasnovas, MD, PhD^9*, Magalie Joris, MD^10,11*, Cristina Castilla-LLorente, MD, PhD^12,13*, Corinne Haioun, MD, PhD^14,15, Olivier Hermine, MD, PhD¹⁶, Michael Loschi, MD, PhD^17*, Sylvain Carras, MD, PhD^18*, Pierre Bories, MD^19*, Tom Fradon^20*, Charles Herbaux^21,22, Pierre Sesques, MD^23*, Steven Le Gouill, MD, PhD²⁴, Franck Morschhauser, MD^25*, Catherine Thieblemont, MD, PhD²⁶ and Roch Houot, Pr, MD, PhD^27*

¹Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie; Université de Paris, Paris, France
²Hematology Department, Hospices Civils de Lyon; Lymphoma Immuno-Biology (LIB) Team, Université Claude Bernard Lyon 1, Lyon, France
³Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
⁴Department of Hematology, University Hospital of Lille, Lille, France
⁵Hematology Department, Nantes University Hospital, Nantes, France
⁶Hematology Department, University Hospital of Nancy, Vandoeuvre, France
⁷Department of Oncology, Hematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France
⁸Department of Haematology, Saint Antoine Hospital, Paris, France
⁹Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France
¹⁰Service d’Hématologie Clinique et Thérapie cellulaire, Centre Hospitalier Universitaire d’Amiens, Amiens, France
¹¹CHU Amiens, Amiens, France
¹²Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
¹³Department of Hematology and INSERM UMR 1030, Université Paris-Saclay, Gustave Roussy Cancer Campus Grand Paris, Paris, France
¹⁴Lymphoid Malignancies Department, Henri Mondor University Hospital/Assistance Publique-Hôpitaux de Paris (AP-HP)/Université Paris-Est Créteil (UPEC), Creteil, France
¹⁵Lymphoid Malignancies Unit, Henri Mondor Hospital, Créteil, France
¹⁶Clinical Hematology, Necker University Hospital, Paris, France
¹⁷Hematology department, CHU de Nice, Universite Cote d'Azur, Nice, France
¹⁸Centre Hospitalier Universitaire Grenoble, La Tronche, FRA
¹⁹Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
²⁰Lymphoma Academic Research Organisation, Pierre-Benite, France
²¹CHU de Montpellier, Montpellier, France
²²Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
²³Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
²⁴Service d'hématologie clinique, CHU de Nantes, Nantes, France
²⁵Centre Hospitalier Régional Universitaire De Lille, Lille, FRA
²⁶Department of Hemato-Oncology, Saint Louis Hospital, Paris, France
²⁷Clinical Hematology, University Hospital Pontchaillou, Rennes Cedex, FRA

Radhika Bansal, MBBS^1*, Sikander Ailawadhi², Jeremy T. Larsen^3*, Morie A Gertz, MD^1,4, Matthew A. Hathcock, M.S.^5*, David Dingli, MD, PhD¹, Prashant Kapoor, MD⁶, Taxiarchis Kourelis, MD¹, Suzanne R. Hayman, MD¹, Rahma M Warsame, MD⁶, Moritz Binder, MD, MPH¹, Ricardo D Parrondo, MD⁷, Rafael Fonseca, MD⁸, P. Leif Bergsagel, MD⁹, Shaji K Kumar, MD⁶ and Yi Lin, MD, PhD⁶

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Jacksonville, FL
³Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, ROCHESTER, MN
⁵Department of Biostatistics, Mayo Clinic, Rochester, MN
⁶Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁸Department of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁹Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ